|Articles|October 1, 2007

Strategies for asymptomatic proteinuria (CME)

A clinical approach to asymptomatic proteinuria can be one of the biggest factors in returning a successful outcome.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!

Related Content

Rationale for supporting the birth dose of hepatitis B vaccine for all newborns

ByDonna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN

December 16th 2025

Mimi C. Lee, MD, PhD, breaks down GeneDx's ExomeDx and GenomeDx tests

ByMimi C. Lee, MD, PhD

December 15th 2025

FDA calls for improved retail recall compliance to protect infants and young children

ByMorgan Ebert, Managing Editor

December 15th 2025

Weekly review: Big week for pediatric FDA approvals

ByJoshua Fitch, Senior Editor

December 15th 2025

Can you diagnose this 19-year-old with painful purpuric nodules on her fingers?

ByIsha Sanghani ,Bernard A Cohen, MD

December 15th 2025

Latest CME

In-Person + Virtual Event

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

January 23, 2026

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Strategies for asymptomatic proteinuria (CME)

Newsletter

Related Content

Rationale for supporting the birth dose of hepatitis B vaccine for all newborns

Mimi C. Lee, MD, PhD, breaks down GeneDx's ExomeDx and GenomeDx tests

FDA calls for improved retail recall compliance to protect infants and young children

Weekly review: Big week for pediatric FDA approvals

Can you diagnose this 19-year-old with painful purpuric nodules on her fingers?

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Meta-analysis finds vegetarian and vegan diets can support healthy growth in children

Mimi C. Lee, MD, PhD, breaks down GeneDx's ExomeDx and GenomeDx tests

FDA approves gepotidacin as oral treatment for urogenital gonorrhea

FDA calls for improved retail recall compliance to protect infants and young children

Weekly review: Big week for pediatric FDA approvals